Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study
Author(s) -
Xia Jiang,
Niki Dimou,
Kawthar Al-Dabhani,
Sarah J. Lewis,
Richard M. Martin,
Philip Haycock,
Marc J. Gunter,
Timothy J. Key,
Rosalind A. Eeles,
Kenneth Muir,
David E. Neal,
Graham G. Giles,
Edward L. Giovannucci,
Meir J. Stampfer,
Brandon L. Pierce,
Joellen M. Schildkraut,
Shaneda Warren Andersen,
Deborah J. Thompson,
Wei Zheng,
Peter Kraft,
Konstantinos K. Tsilidis
Publication year - 2018
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyy284
Subject(s) - mendelian randomization , medicine , prostate cancer , breast cancer , oncology , prostate , randomization , gynecology , cancer , clinical trial , biology , gene , genetics , genetic variants , genotype
Observational studies have suggested an association between circulating vitamin D concentrations [25(OH)D] and risk of breast and prostate cancer, which was not supported by a recent Mendelian randomization (MR) analysis comprising 15 748 breast and 22 898 prostate-cancer cases. Demonstrating causality has proven challenging and one common limitation of MR studies is insufficient power.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom